| HGNC Family | Glycosyltransferases |
| Name | UDP-glucose ceramide glucosyltransferase |
| Description | This gene encodes an enzyme that catalyzes the first glycosylation step in the biosynthesis of glycosphingolipids, which are membrane components containing lipid and sugar moieties. The product of this reaction is glucosylceramide, which is the core structure of many glycosphingolipids. [provided by RefSeq, Dec 2014] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nUDP‐glucose ceramide glucosyltransferase (UGCG) is the sole enzyme responsible for the conversion of ceramide to glucosylceramide—the first and rate‐limiting step in de novo glycosphingolipid biosynthesis. In doing so, UGCG controls the levels of glucosylceramide, which subsequently serves as the precursor for a variety of complex glycosphingolipids that are essential for proper membrane structure, cell signaling, and barrier function. Altered UGCG activity or expression has been implicated in lysosomal storage disorders such as Gaucher disease and Fabry disease, and its modulation can also affect epidermal ceramide composition and the formation of an effective skin permeability barrier."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA wealth of studies in various cancer models indicates that aberrantly high UGCG expression contributes to multidrug resistance by shunting ceramide—a lipid mediator with potent pro‐apoptotic activity—into the non‐cytotoxic glucosylceramide pool. This enzyme‐mediated detoxification of ceramide has been linked to chemoresistance in multiple malignancies including breast, ovarian, thyroid, leukemia, and hepatocellular cancers. UGCG overexpression is frequently associated with enhanced expression of drug efflux transporters (e.g. MDR1/P‐glycoprotein), defective apoptotic signaling (such as impaired p53 function) and a remodeled glycosphingolipid profile that promotes tumor aggressiveness and metastasis. In experimental models, both genetic silencing and pharmacologic inhibition of UGCG have been shown to resensitize tumor cells to cytotoxic agents, thereby underscoring its potential as a therapeutic target."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "28"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its prominent role in cancer biology, UGCG also modulates broader aspects of cellular metabolism and signaling. Changes in UGCG expression can redirect metabolic fluxes—such as increased glutamine oxidation and enhanced mitochondrial turnover—as well as influence oncogenic signaling cascades (including c‐Src/β‐catenin pathways) that regulate proliferation, differentiation, and survival. In addition, UGCG activity has been linked to the regulation of innate immune responses by affecting type I interferon production in plasmacytoid dendritic cells, while its expression is dynamically controlled by factors such as the aryl hydrocarbon receptor and ADP ribosylation factor 6. These diverse roles underscore the enzyme’s importance not only in tumor cell survival but also in processes ranging from antiviral defense and neurobiology to the pathogenesis of inflammatory and mood disorders."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "29", "end_ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ernest Beutler, Carol West "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in glucosylceramide (glucocerebroside) synthase and the Gaucher disease phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Isr Med Assoc J (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12489486"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12489486"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Federica Di Sano, Barbara Fazi, Gennaro Citro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glucosylceramide synthase and its functional interaction with RTN-1C regulate chemotherapeutic-induced apoptosis in neuroepithelioma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12873973"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12873973"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "R W D Welford, A Mühlemann, M Garzotti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddy248"}], "href": "https://doi.org/10.1093/hmg/ddy248"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29982630"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29982630"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Shogo Takeda, Shuko Terazawa, Hiroshi Shimoda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "β-Sitosterol 3-O-D-glucoside increases ceramide levels in the stratum corneum via the up-regulated expression of ceramide synthase-3 and glucosylceramide synthase in a reconstructed human epidermal keratinization model."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0248150"}], "href": "https://doi.org/10.1371/journal.pone.0248150"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33684145"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33684145"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Solène Grazide, Anne-Dominique Terrisse, Sandra Lerouge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M314105200"}], "href": "https://doi.org/10.1074/jbc.M314105200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14766899"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14766899"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Edward Norris-Cervetto, Richard Callaghan, Frances M Platt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M404466200"}], "href": "https://doi.org/10.1074/jbc.M404466200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15263008"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15263008"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Julie Turzanski, Martin Grundy, Shilli Shang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Hematol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.exphem.2004.10.005"}], "href": "https://doi.org/10.1016/j.exphem.2004.10.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15661399"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15661399"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Nina N Sun, Cynthia D Fastje, Simon S Wong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dose-dependent transcriptome changes by metal ores on a human acute lymphoblastic leukemia cell line."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Ind Health (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1191/0748233703th185oa"}], "href": "https://doi.org/10.1191/0748233703th185oa"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15747776"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15747776"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ping Xie, Yun-Fen Shen, Yuan-Ping Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.leukres.2007.07.006"}], "href": "https://doi.org/10.1016/j.leukres.2007.07.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17709137"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17709137"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Neville Marks, Martin J Berg, Mariko Saito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glucosylceramide synthase decrease in frontal cortex of Alzheimer brain correlates with abnormal increase in endogenous ceramides: consequences to morphology and viability on enzyme suppression in cultured primary neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.brainres.2007.10.066"}], "href": "https://doi.org/10.1016/j.brainres.2007.10.066"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18155680"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18155680"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Eugen Ruckhäberle, Thomas Karn, Lars Hanker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Clin Oncol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00432-008-0436-9"}], "href": "https://doi.org/10.1007/s00432-008-0436-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18560890"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18560890"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Yanlin Sun, Tingguo Zhang, Peng Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-009-0513-z"}], "href": "https://doi.org/10.1007/s10549-009-0513-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19693666"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19693666"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Guo-qing Yang, Ke-ming Xie, Yan Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Study on the correlation of GCS and MDR1 genes in inducing multidrug resistance in human K562/A02 cell line]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3760/cma.j.issn.1003-9406.2010.0.014"}], "href": "https://doi.org/10.3760/cma.j.issn.1003-9406.2010.0.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20533270"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20533270"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yong-Yu Liu, Vineet Gupta, Gauri A Patwardhan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1476-4598-9-145"}], "href": "https://doi.org/10.1186/1476-4598-9-145"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20540746"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20540746"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yong-Yu Liu, Gauri A Patwardhan, Kaustubh Bhinge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-3107"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-3107"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21278235"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21278235"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Junya Aida, Syouta Higuchi, Yoshie Hasegawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulation of ceramide glucosyltransferase during the differentiation of U937 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biochem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jb/mvr058"}], "href": "https://doi.org/10.1093/jb/mvr058"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21558327"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21558327"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Yong-Yu Liu, Gauri A Patwardhan, Ping Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2011.1052"}], "href": "https://doi.org/10.3892/ijo.2011.1052"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21617856"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21617856"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jia Guo, Ran Yan, Guo-dong Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HCV NS5A and NS5B enhance expression of human ceramide glucosyltransferase gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Virol Sin (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12250-012-3226-0"}], "href": "https://doi.org/10.1007/s12250-012-3226-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22270805"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22270805"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Vineet Gupta, Kaustubh N Bhinge, Salman B Hosain, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.396390"}], "href": "https://doi.org/10.1074/jbc.M112.396390"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22936806"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22936806"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Xiaofang Zhang, Xiaojuan Wu, Peng Su, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Doxorubicin influences the expression of glucosylceramide synthase in invasive ductal breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0048492"}], "href": "https://doi.org/10.1371/journal.pone.0048492"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23133636"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23133636"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Ke Zhang, Ying-Hua Song, Xiao-Yan Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of glucosylceramide synthase protein in papillary thyroid carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Chin Med J (Engl) (2013)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24342307"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24342307"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Jiannan Liu, Ping Sun, Yuan Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of glucosylceramide synthase in invasive ductal breast cancer may be correlated with high estrogen receptor status and low HER-2 status."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diagn Pathol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1746-1596-9-22"}], "href": "https://doi.org/10.1186/1746-1596-9-22"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24456584"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24456584"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Xiufen Zhang, Keming Xie, Jian Zou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[NF-κ B mediates the effect of glucosylceramide synthase on P-glycoprotein modulation in a drug-resistance leukemia cell line]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3760/cma.j.issn.1003-9406.2014.01.008"}], "href": "https://doi.org/10.3760/cma.j.issn.1003-9406.2014.01.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24510559"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24510559"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yie Hou Lee, Chin Wen Tan, Abhishek Venkatratnam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysregulated sphingolipid metabolism in endometriosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2014-1340"}], "href": "https://doi.org/10.1210/jc.2014-1340"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24960545"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24960545"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "C Wang, J N Liu, L Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and significance of glucosylceramide synthase in colorectal carcinoma tissues."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2014)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25535133"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25535133"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Milica Stefanovic, Anna Tutusaus, Guillermo A Martinez-Nieto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6982"}], "href": "https://doi.org/10.18632/oncotarget.6982"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26811497"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26811497"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Yasuhiro Hayashi, Yoko Nemoto-Sasaki, Naoki Matsumoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA118.002048"}], "href": "https://doi.org/10.1074/jbc.RA118.002048"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30242129"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30242129"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Nina Schömel, Sarah E Hancock, Lisa Gruber, et al. "}, {"type": "b", "children": [{"type": "t", "text": "UGCG influences glutamine metabolism of breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-019-52169-7"}], "href": "https://doi.org/10.1038/s41598-019-52169-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31666638"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31666638"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Barbara Fazi, Sonia Melino, Federica Di Sano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cloning, expression, and preliminary structural characterization of RTN-1C."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2006.02.036"}], "href": "https://doi.org/10.1016/j.bbrc.2006.02.036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16500619"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16500619"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Nina Schömel, Lisa Gruber, Stephanie J Alexopoulos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "UGCG overexpression leads to increased glycolysis and increased oxidative phosphorylation of breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-020-65182-y"}], "href": "https://doi.org/10.1038/s41598-020-65182-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32424263"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32424263"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Takuya Honda, Kaisei Motoyoshi, Junya Kasahara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tyrosine-phosphorylation and activation of glucosylceramide synthase by v-Src: Its role in survival of HeLa cells against ceramide."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Mol Cell Biol Lipids (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbalip.2020.158817"}], "href": "https://doi.org/10.1016/j.bbalip.2020.158817"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32980536"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32980536"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Carrie Hayes Sutter, Shafquat Azim, Anyou Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ligand Activation of the Aryl Hydrocarbon Receptor Upregulates Epidermal Uridine Diphosphate Glucose Ceramide Glucosyltransferase and Glucosylceramides."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jid.2023.03.1662"}], "href": "https://doi.org/10.1016/j.jid.2023.03.1662"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37004877"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37004877"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Silvia La Monica, Federica Vacondio, Kamal Eltayeb, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-024-57028-8"}], "href": "https://doi.org/10.1038/s41598-024-57028-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38499619"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38499619"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Razvan-Marius Brazdis, Claudia von Zimmermann, Bernd Lenz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peripheral Upregulation of Parkinson's Disease-Associated Genes Encoding α-Synuclein, β-Glucocerebrosidase, and Ceramide Glucosyltransferase in Major Depression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms25063219"}], "href": "https://doi.org/10.3390/ijms25063219"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38542193"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38542193"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Yohei Sato, Erika Osada, Takashi Ushiki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "UDP-glucose ceramide glucosyltransferase specifically upregulated in plasmacytoid dendritic cells regulates type I interferon production upon CpG stimulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2024.150703"}], "href": "https://doi.org/10.1016/j.bbrc.2024.150703"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39307111"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39307111"}]}]}]}
|
| Synonyms | GCS |
| Proteins | CEGT_HUMAN |
| NCBI Gene ID | 7357 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
UGCG has 13,064 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 129 datasets.
Click the + buttons to view associations for UGCG from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by UGCG gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of UGCG gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of UGCG gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of UGCG gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of UGCG gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of UGCG gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of UGCG gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of UGCG gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of UGCG gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of UGCG gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of UGCG gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of UGCG gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with UGCG protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with UGCG gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of UGCG gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of UGCG gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of UGCG gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of UGCG gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing UGCG protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing UGCG protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with UGCG protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with UGCG protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of UGCG gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with UGCG gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with UGCG gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with UGCG gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with UGCG gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of UGCG protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by UGCG gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with UGCG gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with UGCG gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with UGCG gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with UGCG gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for UGCG protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at UGCG gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of UGCG gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of UGCG gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing UGCG from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with UGCG gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with UGCG gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of UGCG gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with UGCG gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing UGCG from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of UGCG gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of UGCG gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of UGCG gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of UGCG gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of UGCG gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of UGCG gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving UGCG gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving UGCG gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving UGCG gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing UGCG protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing UGCG protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing UGCG protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by UGCG gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by UGCG gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by UGCG gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of UGCG gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of UGCG gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of UGCG gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of UGCG gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding UGCG receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with UGCG gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with UGCG gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with UGCG gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of UGCG gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for UGCG protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of UGCG gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of UGCG gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of UGCG protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of UGCG gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for UGCG from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with UGCG gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with UGCG gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with UGCG gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with UGCG gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by UGCG gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for UGCG protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of UGCG gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of UGCG gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of UGCG gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving UGCG protein from the KEGG Pathways dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of UGCG gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of UGCG gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with UGCG gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of UGCG gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of UGCG gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of UGCG gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of UGCG gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing UGCG protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain UGCG protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by UGCG gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting UGCG gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of UGCG gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of UGCG gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by UGCG gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of UGCG gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for UGCG protein from the MW Gene Metabolite Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of UGCG gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for UGCG from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of UGCG gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of UGCG gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving UGCG protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving UGCG protein from the Wikipathways PFOCR 2024 dataset. | |
| PID Pathways | pathways involving UGCG protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving UGCG protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving UGCG protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of UGCG gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of UGCG gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of UGCG gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of UGCG gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of UGCG gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at UGCG gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of UGCG gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of UGCG gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of UGCG gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of UGCG gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of UGCG gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of UGCG gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of UGCG gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of UGCG gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of UGCG protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of UGCG protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of UGCG protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of UGCG protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with UGCG protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with UGCG protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving UGCG protein from the WikiPathways Pathways 2024 dataset. | |